menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Investors are plunking billions of dollars into AI-focused biopharma companies—a more than 300% increase from 2023

12 0
31.01.2025
Investors put $5.6 billion into such companies, which develop drugs made of biological sources like vaccines.

© Fortune